Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer

This study has been completed.

Study NCT00073996 Information provided by National Cancer Institute (NCI)

First Received: December 10, 2003 Last Updated: November 26, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)